InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: None

Thursday, 08/15/2013 5:40:06 PM

Thursday, August 15, 2013 5:40:06 PM

Post# of 146240
Met with Dr. Seymour over lunch:

Some bullet points of things we discussed, none of which was not already public discussion from the company and officers:

-New site construction is ahead of schedule and should finish at the least on time. (This meeting was early Monday before this info was confirmed by NNVCbob onsite observations).

-Wants to move Dengue and flu simultaneously and has the money to do it.

-Because Dengue can't be tested through a challenge protocol with patients inoculated with the virus (made sick with Dengue then treated), it may be approved with only small phase 1/2a under orphan drug/breakthrough.

-In the coming months he will be reporting progress for EKC, HSV, HIV studies and general nanoviricide tweaking.

-IMO, the biggest thing, Anil was able to develop the MERS solution in less than a week. Less than a week for the type that will be tested in EU is pretty amazing and beats the 3 weeks of the rapid in field technology they previously talked about.

-Looking for an Aspire type deal for future money needs.

-Now looking to go it alone by a strategy of contract manufacturing and alternative avenues of distribution. At this point, he sees no reason to hand over a nanoviricide license after Anil and crew have done all the work, and that license in return for the smallest percentage. (I think this could change with the right deal, a partnership with 50/50 split and the partner picks up the remaining costs plus pays huge benchmarks. Those deals are out there.)

Stopping a run with a "fake wall."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News